Literature DB >> 16799960

TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.

Jian Zhao1, Xia Zhang, Mei Shi, Hao Xu, Jun Jin, Haidong Ni, Silei Yang, Jianxin Dai, Mengchao Wu, Yajun Guo.   

Abstract

Hepatocellular carcinoma (HCC) is an aggressive cancer with a poor prognosis. The specific cellular gene alterations responsible for hepatocarcinogenesis are not well known. Previous works showed that loss of TIP30, also called CC3, a putative tumor suppressor, increased the incidence of hepatocellular carcinoma in mice, and some clinical samples of human HCC tissues had aberrant expression of TIP30. Here, we report that the introduction of TIP30 by an adenovirus vector into HCC cell lines that had decreased expressions of TIP30 inhibited cell proliferation, decreased anchorage-dependent growth, suppressed invasion through the extracellular matrix, and inhibited tumorigenesis in nude mice. Moreover, exogenous expression of Tip30 sensitized HCC cells to cytotoxic drugs and to apoptosis induced by tumor necrosis factor-related ligands in vitro. Ectopic expression of TIP30 in HCC cells enhanced p53 expression and decreased Bcl-2/Bcl-xL expression. Treatment of nude mice bearing subcutaneously established HCC tumors with a combination of an adenovirus expressing TIP30 and the cytotoxic drug 5-fluorouracil completely suppressed tumor growth and prolonged survival. In conclusion, TIP30 may play an important role in the suppression of hepatocarcinogenesis by acting as a tumor suppressor. Overexpression of TIP30 might be a promising candidate as a treatment for HCC that would increase sensitivity to chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799960     DOI: 10.1002/hep.21213

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

Review 1.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 2.  Clinical implications of DNA methylation in hepatocellular carcinoma.

Authors:  Eric L Sceusi; David S Loose; Curtis J Wray
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

3.  Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinoma.

Authors:  Jianqiu Chen; Chunsheng Zhu; Minhui Zhu; Ming Geng; Yongsheng Tian; Guojun Li; Hongliang Zheng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Adenoviral gene therapy in hepatocellular carcinoma: a review.

Authors:  Iván Lyra-González; Laura Esther Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  Hepatol Int       Date:  2012-04-25       Impact factor: 6.047

5.  Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.

Authors:  Gui-Jun Zhao; Li-Xia Xu; Eagle S H Chu; Ning Zhang; Jia-Yun Shen; Alatangaole Damirin; Xiao-Xing Li
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

6.  CC3/TIP30 affects DNA damage repair.

Authors:  Sylvia Fong; Frank King; Emma Shtivelman
Journal:  BMC Cell Biol       Date:  2010-04-07       Impact factor: 4.241

7.  Decreased TIP30 expression promotes tumor metastasis in lung cancer.

Authors:  Xin Tong; Kai Li; Zhigang Luo; Bin Lu; Xing Liu; Tao Wang; Mingshu Pang; Beibei Liang; Min Tan; Mengchao Wu; Jian Zhao; Yajun Guo
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

8.  TIP30 directly binds p53 tumor suppressor protein in vitro.

Authors:  Si-Hyung Lee; Sung-Kyu Ju; Tae-Young Lee; Sung-Ho Huh; Kyou-Hoon Han
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

9.  Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma.

Authors:  Lu Lu; Hui-Chuan Sun; Wei Zhang; Zong-Tao Chai; Xiao-Dong Zhu; Ling-Qun Kong; Wen-Quan Wang; Ke-Zhi Zhang; Yuan-Yuan Zhang; Qiang-Bo Zhang; Jian-Yang Ao; Jia-Qi Li; Lu Wang; Wei-Zhong Wu; Zhao-You Tang
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker.

Authors:  Yakup Kumtepe; Zekai Halici; Ozlem Sengul; Celalettin Semih Kunak; Yasin Bayir; Nergiz Kilic; Elif Cadirci; Alparslan Pulur; Zafer Bayraktutan
Journal:  Eur J Med Res       Date:  2013-06-24       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.